|
gptkbp:instanceOf
|
gptkb:public_health_intervention
|
|
gptkbp:administeredBy
|
healthcare professionals
|
|
gptkbp:administeredWorldwide
|
over 13 billion doses (as of 2023)
|
|
gptkbp:aimsTo
|
prevent COVID-19 infection
|
|
gptkbp:approvedBy
|
gptkb:World_Health_Organization
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration
|
|
gptkbp:beganIn
|
2020
|
|
gptkbp:canBeAdministeredAs
|
intramuscular injection
nasal spray (in some cases)
|
|
gptkbp:contraindication
|
people with severe allergic reactions to vaccine components
|
|
gptkbp:distributionBegan
|
December 2020
|
|
gptkbp:effectivenessVariesBy
|
gptkb:virus_variant
vaccine type
|
|
gptkbp:includesVaccine
|
gptkb:Covovax
gptkb:AstraZeneca_COVID-19_vaccine
gptkb:Covaxin
gptkb:Johnson_&_Johnson_COVID-19_vaccine
gptkb:Moderna_COVID-19_vaccine
gptkb:Pfizer-BioNTech_COVID-19_vaccine
gptkb:Sinovac_COVID-19_vaccine
gptkb:Sputnik_V_COVID-19_vaccine
gptkb:Sinopharm_COVID-19_vaccine
|
|
gptkbp:monitors
|
gptkb:Centers_for_Disease_Control_and_Prevention
gptkb:World_Health_Organization
national health agencies
|
|
gptkbp:partOf
|
gptkb:COVID-19
|
|
gptkbp:recommendation
|
gptkb:Centers_for_Disease_Control_and_Prevention
gptkb:World_Health_Organization
adults
children (in some countries)
|
|
gptkbp:reduces
|
hospitalization
severe COVID-19
death from COVID-19
|
|
gptkbp:reducesTransmissionOf
|
gptkb:COVID-19
|
|
gptkbp:requires
|
booster doses
international travel (in some countries)
|
|
gptkbp:sideEffect
|
fever
fatigue
headache
muscle pain
chills
injection site pain
|
|
gptkbp:subjectOf
|
public health campaigns
vaccine hesitancy
misinformation
|
|
gptkbp:supportedBy
|
COVAX initiative
|
|
gptkbp:uses
|
gptkb:COVID-19_vaccines
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
COVID-19 Vaccination
|